Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) had its target price hoisted by analysts at Scotiabank from $19.00 to $20.00 in a research note issued on Monday,Benzinga reports. The firm currently has a "sector perform" rating on the real estate investment trust's stock. Scotiabank's price objective suggests a potential upside of 8.27% from the stock's current price.
Separately, Truist Financial upped their price objective on shares of Sabra Healthcare REIT from $17.00 to $18.00 and gave the stock a "hold" rating in a report on Tuesday, March 18th. Three research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $19.67.
Check Out Our Latest Report on Sabra Healthcare REIT
Sabra Healthcare REIT Trading Up 1.2%
Shares of NASDAQ:SBRA traded up $0.22 during midday trading on Monday, hitting $18.47. 154,535 shares of the stock traded hands, compared to its average volume of 2,280,537. The company has a quick ratio of 4.22, a current ratio of 4.22 and a debt-to-equity ratio of 0.89. The business's 50 day moving average is $17.79 and its two-hundred day moving average is $17.26. The stock has a market capitalization of $4.40 billion, a PE ratio of 31.36, a P/E/G ratio of 1.38 and a beta of 0.85. Sabra Healthcare REIT has a one year low of $14.63 and a one year high of $20.03.
Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last released its quarterly earnings data on Monday, May 5th. The real estate investment trust reported $0.37 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.01. Sabra Healthcare REIT had a return on equity of 5.14% and a net margin of 19.55%. The business had revenue of $183.54 million during the quarter, compared to analysts' expectations of $180.23 million. During the same quarter last year, the business posted $0.35 EPS. The business's revenue was up 10.1% on a year-over-year basis. As a group, research analysts forecast that Sabra Healthcare REIT will post 1.45 earnings per share for the current year.
Insider Buying and Selling
In other news, Director Michael J. Foster sold 11,000 shares of the stock in a transaction on Tuesday, May 20th. The stock was sold at an average price of $18.22, for a total value of $200,420.00. Following the sale, the director now directly owns 64,725 shares of the company's stock, valued at approximately $1,179,289.50. This represents a 14.53% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 1.10% of the stock is owned by company insiders.
Institutional Trading of Sabra Healthcare REIT
Several institutional investors have recently bought and sold shares of SBRA. VSM Wealth Advisory LLC bought a new position in shares of Sabra Healthcare REIT in the fourth quarter worth approximately $26,000. SVB Wealth LLC bought a new position in Sabra Healthcare REIT in the 1st quarter valued at approximately $34,000. UMB Bank n.a. boosted its stake in Sabra Healthcare REIT by 379.6% during the 1st quarter. UMB Bank n.a. now owns 2,048 shares of the real estate investment trust's stock valued at $36,000 after purchasing an additional 1,621 shares during the last quarter. Wealth Preservation Advisors LLC purchased a new stake in Sabra Healthcare REIT during the 1st quarter valued at $38,000. Finally, Assetmark Inc. increased its holdings in shares of Sabra Healthcare REIT by 33.4% in the 4th quarter. Assetmark Inc. now owns 2,618 shares of the real estate investment trust's stock worth $45,000 after purchasing an additional 656 shares in the last quarter. 99.40% of the stock is owned by hedge funds and other institutional investors.
About Sabra Healthcare REIT
(
Get Free Report)
Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Sabra Healthcare REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Healthcare REIT wasn't on the list.
While Sabra Healthcare REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
